Project: Biosimilar For Acute Stroke Theranostic
| Acronym | BIOFAST (Reference Number: 11333) |
| Duration | 04/12/2017 |
| Project Topic | Our stroke project consists in (1) producing a biosimilar to recombinant plasminogen activator (biosimilar tPa) with novel bioprocessing methods under "Good Manufacturing Practices" (GMP), (2) planning and conducting a phase I clinical study to evaluate the therapeutic. Upon success of the BIOFAST project, a final phase 1 clinical report will allow us to launch phase 3 clinical trial within 6 months of project completion. |
| Network | Eurostars 2 |
| Call | Eurostars Cut-Off 7 |
Project partner
| Number | Name | Role | Country |
|---|---|---|---|
| 1 | Prediction BioSciences SAS | Coordinator | France |
| 2 | Celonic AG | Partner | Switzerland |